Medifast, Inc.
MED
$12.57
$0.171.37%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.26% | -16.01% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.26% | -16.01% | |||
| Cost of Revenue | 5.80% | -15.76% | |||
| Gross Profit | -0.74% | -16.12% | |||
| SG&A Expenses | -4.76% | -9.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.66% | -11.33% | |||
| Operating Income | 29.78% | -91.20% | |||
| Income Before Tax | 69.59% | -140.20% | |||
| Income Tax Expenses | -98.46% | 3,063.89% | |||
| Earnings from Continuing Operations | 88.29% | -701.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 88.29% | -701.37% | |||
| EBIT | 29.78% | -91.20% | |||
| EBITDA | 53.99% | -589.67% | |||
| EPS Basic | 88.30% | -701.41% | |||
| Normalized Basic EPS | 36.10% | -140.17% | |||
| EPS Diluted | 88.30% | -685.00% | |||
| Normalized Diluted EPS | 36.10% | -140.17% | |||
| Average Basic Shares Outstanding | 0.14% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.14% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||